South San Francisco, CA, United States of America

Jing Yuan Ma

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Austin, TX (US) (2020)
  • South San Francisco, CA (US) (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations of Jing Yuan Ma in Anti-Cancer Research

Introduction

Jing Yuan Ma is a notable inventor based in South San Francisco, CA, with a significant contribution to the field of anti-cancer research. He holds a total of six patents, showcasing his dedication to developing innovative solutions for cancer treatment. His work primarily focuses on the creation of novel compounds that can potentially improve therapeutic outcomes for cancer patients.

Latest Patents

Among his latest patents are the "Nitrobenzyl derivatives of anti-cancer agents." These patents detail compounds of formula I, where the variables are defined within the documentation. The processes for making these compounds and methods for treating cancer through their administration are also outlined. This innovative approach aims to provide new avenues for effective cancer therapies.

Career Highlights

Jing Yuan Ma has worked with prominent companies in the pharmaceutical industry, including Obi Pharma Inc. and Molecular Templates, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Jian-Xin Duan and Yeyu Cao, who have also played significant roles in advancing research in cancer treatment.

Conclusion

Jing Yuan Ma's contributions to anti-cancer research through his patents and collaborations highlight his commitment to innovation in the medical field. His work continues to inspire advancements in cancer therapies, making a meaningful impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…